Mustapha Gidado

Executive Director

Mustapha Gidado has over 25 years of experience in improving public health outcomes in TB, TB/HIV, MDR-TB & Leprosy in a variety of healthcare settings from health care facility to national and global level. He has extensive know-how in program design, planning, implementation, monitoring and translating science into practice. Previously, a Deputy Director of the Federal Ministry of Health, Nigeria, and had a progressive career with KNCV Tuberculosis Foundation and currently the Executive Director of the Global KNCV TB Plus, The Hague.

Mustapha was previously the global director of the USAID funded Challenge TB Project and the KNCV Tuberculosis Foundation’s country representative and director of projects for the Nigeria. As the director of the Challenge TB Project, Mustapha was responsible for delivering the US$500m flagship global project to implement USAID’s TB strategy: collaborating with other national and international initiatives in providing global leadership and support for national TB control efforts.

Mustapha has extensive experience working at all levels of government and with technical and funding partners, including the Global Fund, WHO, and USAID. Mustapha’s competencies include program leadership and management, TB & TB/HIV, programmatic management of drug resistant TB, TB infection control, resource mobilisation and human resource development.

Mustapha has co-authored 52 peered review articles, 17 book chapters, and policy documents and guidelines on TB, TB/HIV, laboratory & Leprosy, and co-presented over 110 international conference abstracts/seminars. He is a faculty member/guest lecturer at several Universities in the Netherlands and Nigeria. He is also active in several international TB platforms, discussions, and reviews, including being an observer for over six years at the WHO Strategic Technical Advisory Group for TB.

Recent publications

  1. Gordon I, Odume B, Ogbudebe C, Chukwuogo O, Nwokoye N, Useni S, Gidado M et al. Perception, acceptability and challenges of digital adherence technology among TB healthcare workers. Public Health Action. June 1, 2024.
  2. Ogbudebe C, Odume B, Gordon I, Chukwuogo O, Nwokoye N, Gidado M et al. Appraising perception, accessibility and uptake of DAT among patients with TB. Public Health Action. June 1, 2024.
  3. van der Westhuizen H, Nice JA, Tudor C, Liu Y, Ahmedov S, Kansal AR, Jensen PA, Vincent RL, Gidado M, Vauhkonen V, Ochoa Delgado IM, van der Walt M, Volchenkov G. Embracing novel thinking to safeguard against airborne pathogens in indoor spaces. IJTLD Open;1(6):239-241. June 1, 2024.
  4. Nwokoye N, Odume B, Nwadike P, Anaedobe I, Mangoro Z, Umoren M, Ogbudebe C, Chukwuogo O, Useni S, Nongo D, Eneogu R, Elom E, de Haas PGidado M. Impact of the Stool-Based Expert Test on Childhood Tuberculosis Diagnosis in Selected States in Nigeria. Trop. Med. Infect. Dis., May 1, 2024.
  5. Mitchell E, Adejumo OA, Abdur-Razzaq H, Ogbudebe C, Gidado M . The role of trust as a driver of private provider participation in disease surveillance: Cross-sectional survey from Nigeria . JMIR Public Health Surveillance. 2024.
  6. Reid M, Agbassi YJP, Arinaminpathy N, Bercasio A, Bhargava A, Gidado M et al. Scientific advances and the end of tuberculosis: a report from the Lancet Commission on Tuberculosis. Lancet 2023.
  7. Mitchell EMH, Adejumo OA, Abdur-Razza H, Ogbudebe C, Gidado M et al. Hybrid Approach to Estimation of Underreporting of Tuberculosis Case Notification in High- Burden Settings With Weak Surveillance Infrastructure: Design and Implementation of an Inventory Study. JMIR Public Health Surveill 2021 (7)| iss. 3 | e22352.
  8. Onazi O, Adejumo AO, Redwood L, Gidado M, Daniel OJ, Mitchell EMH. et al. Community health care workers in pursuit of TB: Discourses and dilemmas. Soc Sci Med. 2020;246:112756.
  9. Adejumo OA, Olusola-Faleye B, Adepoju VA, Gidado M, Onoh MO, Adegboye O, et al. The pattern of comorbidity and its prevalence among drug-resistant tuberculosis patients at treatment initiation in Lagos, Nigeria. Trans R Soc Trop Med Hyg. 2020;114(6):415-423.

 

read all the KNCV publications

KNCV has been fighting TB since its establishment in 1903. Over the past 120 years, the organization has acquired indispensable knowledge and experience in the field of effective TB prevention and care, resulting in pre-elimination in the Netherlands and significant contributions to global evidence generation, policy development and TB program implementation worldwide.

Our experts
KNCV governance framework and integrity
Our patroness
Partner with us

Sorry

De versie van de browser die je gebruikt is verouderd en wordt niet ondersteund.
Upgrade je browser om de website optimaal te gebruiken.